T80.A10S Non-ABO incompatibility with acute hemolytic transfusion reaction, sequela

Name of the Condition

• Non-ABO incompatibility with acute hemolytic transfusion reaction, sequela.

Summary

This condition describes the residual effects or chronic complications resulting from a prior non-ABO incompatibility with acute hemolytic transfusion reaction. It represents the long-term consequences of the initial reaction, which occurred due to immune-mediated destruction of red blood cells from non-ABO antigen mismatches. The "sequela" designation indicates this is a late effect or complication following the acute event.

Causes

Sequela of non-ABO incompatibility with acute hemolytic transfusion reaction arise from the initial immune response to minor blood group antigens (e.g., Rh, Kell, Duffy, or Kidd systems) or antibodies against platelet or plasma proteins. The acute reaction may have caused tissue damage, organ dysfunction, or persistent immune activation, leading to ongoing clinical manifestations.

Risk Factors

• Prior exposure to incompatible blood products
• History of multiple transfusions or pregnancies
• Underlying immune-mediated conditions
• Use of blood products with non-ABO antigen mismatches
• Lack of pre-transfusion antibody screening in high-risk patients

Symptoms

• Persistent fatigue or anemia
• Chronic renal impairment or oliguria
• Jaundice or elevated bilirubin levels
• Recurrent hemolysis (evidenced by dark urine)
• Delayed immune reactions or sensitization

Diagnosis

Diagnosis involves correlating the patient’s history of a prior non-ABO incompatibility with acute hemolytic transfusion reaction to current clinical findings. Laboratory tests may include hemoglobin levels, bilirubin, renal function tests, and antibody screening to confirm residual effects. Imaging or organ function assessments may be used to evaluate complications.

Treatment Options

Management focuses on addressing residual complications, such as anemia, renal dysfunction, or immune sensitization. This may include blood transfusions (with compatible units), renal support, or immunosuppressive therapy. Long-term monitoring and preventive measures for future transfusions are essential.

Prognosis and Follow-Up

Prognosis depends on the severity of the initial reaction and resulting complications. Regular follow-up is necessary to monitor for delayed effects, such as chronic kidney disease or recurrent hemolysis. Preventive strategies, including thorough antibody screening, are critical to avoid future reactions.

Complications

• Chronic kidney disease or renal failure
• Persistent anemia or hemolysis
• Immune sensitization to blood products
• Organ damage from the initial reaction
• Increased risk of future transfusion reactions

Lifestyle & Prevention

• Ensure thorough pre-transfusion antibody screening for high-risk patients.
• Use cross-matched blood products to minimize antigen mismatches.
• Maintain clear documentation of transfusion history and reactions.
• Follow up with healthcare providers after transfusions to monitor for delayed effects.

When to Seek Professional Help

Seek immediate medical attention if symptoms of hemolysis (e.g., dark urine, jaundice) or organ dysfunction (e.g., reduced urine output, shortness of breath) occur after a transfusion. Persistent fatigue, anemia, or unexplained symptoms should also prompt evaluation.

Tips for Medical Coders

Document the relationship between the sequela and the prior non-ABO incompatibility with acute hemolytic transfusion reaction. Ensure the code T80.A10S is used only when the condition is a late effect of the acute reaction. Include details of the initial event and current clinical manifestations to support coding accuracy.